Cargando…
Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review
This narrative review aims to report the main clinical manifestations, therapeutic strategies, outcomes, and complications of acute SARS-CoV-2 infection in childhood and to summarize the data relating the SARS-CoV-2 vaccination efficacy and safety in pediatric age. SARS-CoV-2 infection mostly occurs...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673592/ https://www.ncbi.nlm.nih.gov/pubmed/38004076 http://dx.doi.org/10.3390/medicina59112027 |
_version_ | 1785149621457125376 |
---|---|
author | Mastrolia, Maria Vincenza De Cillia, Camilla Orlandi, Michela Abu-Rumeileh, Sarah Maccora, Ilaria Maniscalco, Valerio Marrani, Edoardo Pagnini, Ilaria Simonini, Gabriele |
author_facet | Mastrolia, Maria Vincenza De Cillia, Camilla Orlandi, Michela Abu-Rumeileh, Sarah Maccora, Ilaria Maniscalco, Valerio Marrani, Edoardo Pagnini, Ilaria Simonini, Gabriele |
author_sort | Mastrolia, Maria Vincenza |
collection | PubMed |
description | This narrative review aims to report the main clinical manifestations, therapeutic strategies, outcomes, and complications of acute SARS-CoV-2 infection in childhood and to summarize the data relating the SARS-CoV-2 vaccination efficacy and safety in pediatric age. SARS-CoV-2 infection mostly occurs asymptomatically in the pediatric population, while multisystem inflammatory syndrome in children (MIS-C) represents the most severe coronavirus disease 2019 (COVID-19)-related illness, a life-threatening event with a high morbidity rate. After the development of SARS-CoV-2 vaccines and their subsequent approval in children, the rate of infection as well as the number of its related complications have shown a drastic decrease. Fully vaccinated children are protected from the risk of developing a severe disease and a similar protective role has been observed in the reduction of complications, in particular MIS-C. However, long-lasting immunity has not been demonstrated, booster doses have been required, and reinfection has been observed. With regards to vaccine safety, adverse events were generally mild to moderate in all age groups: local adverse events were the most commonly reported. Nevertheless, a potential association between SARS-CoV-2 vaccine and the subsequent development of inflammatory manifestations has been suggested. Myocarditis has rarely been observed following vaccination; it appeared to be more frequent among adolescent males with a mild clinical course leading to a complete recovery. SARS-CoV-2 vaccine-related MIS-C cases have been described, although a univocal definition and an exact time interval with respect to vaccination has not been reported, thus not establishing a direct causal link. Current evidence about COVID-19 vaccination in children and adolescents suggest that benefits outweigh potential risks. Long-term data collection of the post-authorization safety surveillance programs will better define the real incidence of SARS-CoV-2 vaccine-related complications in the pediatric population. |
format | Online Article Text |
id | pubmed-10673592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106735922023-11-17 Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review Mastrolia, Maria Vincenza De Cillia, Camilla Orlandi, Michela Abu-Rumeileh, Sarah Maccora, Ilaria Maniscalco, Valerio Marrani, Edoardo Pagnini, Ilaria Simonini, Gabriele Medicina (Kaunas) Review This narrative review aims to report the main clinical manifestations, therapeutic strategies, outcomes, and complications of acute SARS-CoV-2 infection in childhood and to summarize the data relating the SARS-CoV-2 vaccination efficacy and safety in pediatric age. SARS-CoV-2 infection mostly occurs asymptomatically in the pediatric population, while multisystem inflammatory syndrome in children (MIS-C) represents the most severe coronavirus disease 2019 (COVID-19)-related illness, a life-threatening event with a high morbidity rate. After the development of SARS-CoV-2 vaccines and their subsequent approval in children, the rate of infection as well as the number of its related complications have shown a drastic decrease. Fully vaccinated children are protected from the risk of developing a severe disease and a similar protective role has been observed in the reduction of complications, in particular MIS-C. However, long-lasting immunity has not been demonstrated, booster doses have been required, and reinfection has been observed. With regards to vaccine safety, adverse events were generally mild to moderate in all age groups: local adverse events were the most commonly reported. Nevertheless, a potential association between SARS-CoV-2 vaccine and the subsequent development of inflammatory manifestations has been suggested. Myocarditis has rarely been observed following vaccination; it appeared to be more frequent among adolescent males with a mild clinical course leading to a complete recovery. SARS-CoV-2 vaccine-related MIS-C cases have been described, although a univocal definition and an exact time interval with respect to vaccination has not been reported, thus not establishing a direct causal link. Current evidence about COVID-19 vaccination in children and adolescents suggest that benefits outweigh potential risks. Long-term data collection of the post-authorization safety surveillance programs will better define the real incidence of SARS-CoV-2 vaccine-related complications in the pediatric population. MDPI 2023-11-17 /pmc/articles/PMC10673592/ /pubmed/38004076 http://dx.doi.org/10.3390/medicina59112027 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mastrolia, Maria Vincenza De Cillia, Camilla Orlandi, Michela Abu-Rumeileh, Sarah Maccora, Ilaria Maniscalco, Valerio Marrani, Edoardo Pagnini, Ilaria Simonini, Gabriele Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review |
title | Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review |
title_full | Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review |
title_fullStr | Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review |
title_full_unstemmed | Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review |
title_short | Clinical Syndromes Related to SARS-CoV-2 Infection and Vaccination in Pediatric Age: A Narrative Review |
title_sort | clinical syndromes related to sars-cov-2 infection and vaccination in pediatric age: a narrative review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673592/ https://www.ncbi.nlm.nih.gov/pubmed/38004076 http://dx.doi.org/10.3390/medicina59112027 |
work_keys_str_mv | AT mastroliamariavincenza clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview AT decilliacamilla clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview AT orlandimichela clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview AT aburumeilehsarah clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview AT maccorailaria clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview AT maniscalcovalerio clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview AT marraniedoardo clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview AT pagniniilaria clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview AT simoninigabriele clinicalsyndromesrelatedtosarscov2infectionandvaccinationinpediatricageanarrativereview |